Efficacy and Safety of Docetaxel Plus Prednisolone Chemotherapy for Metastatic Hormone-Refractory Prostate Adenocarcinoma: Single Institutional Study in Korea

PURPOSE: To assess the efficacy and safety of treating Korean patients with metastatic hormone-refractory prostate cancer (HRPC) using docetaxel plus prednisolone chemotherapy. MATERIALS AND METHODS: This was a retrospective cohort study performed in 98 patients with metastatic HRPC between October...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Lee, Jae-Lyun, Kim, Jeong Eun, Ahn, Jin-Hee, Lee, Dae-Ho, Lee, Jungshin, Kim, Choung-Soo, Hong, Jun Hyuk, Hong, Bumsik, Song, Cheryn, Ahn, Hanjong
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Korean Cancer Association 2010
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2848748/
https://ncbi.nlm.nih.gov/pubmed/20369046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.1.12
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg